




The aim of this article is to highlight practical recommendations based on our experience as reviewers and journal editors and refer to some most 
common mistakes in manuscripts submitted to Biochemia Medica. One of the most important parts of the article is the Abstract. Authors quite often 
forget that Abstract is sometimes the fi rst (and only) part of the article read by the readers. The article Abstract must therefore be comprehensive 
and provide key results of your work. Problematic part of the article, also often neglected by authors is the subheading Statistical analysis, within 
Materials and methods, where authors must explain which statistical tests were used in their data analysis and the rationale for using those tests. 
They also need to make sure that all tests used are listed under Statistical analysis section, as well as that all tests listed are indeed used in the study. 
When writing Results section there are several key points to keep in mind, such as: are results presented with adequate precision and accurately; is 
descriptive analysis appropriate; is the measure of confi dence provided for all estimates; if necessary and applicable, are correct statistical tests used 
for analysis; is P value provided for all tests, etc. Especially important is not to make any conclusions on the causal relationship unless the study is 
an experiment or clinical trial. We believe that the use of the proposed checklist might increase the quality of the submitted work and speed up the 
peer-review and publication process for published articles.
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Introduction
The Editors at Biochemia Medica are committed to 
continuously improve the quality of the articles 
published in the Journal. This may be achieved by 
helping authors to improve their manuscripts 
through peer-review process. One of the major 
problems in manuscripts submitted to Biochemia 
Medica is the quality of the data analysis and data 
presentation. The improper use of statistical meth-
ods is unethical because it leads to biased results 
and incorrect conclusions. Moreover, this is a sub-
stantial waste of time and money. The most com-
mon errors occurring in Biochemia Medica have al-
ready been reported in this Journal (1).
To improve the quality of data analysis and report-
ing in manuscripts submitted for possible publica-
tion, the increasing number of journals have issued 
statistical guidelines and have also introduced the 
statistical editors who are responsible for statisti-
cal peer-review (2-4).
The aim of this article is to provide practical rec-
ommendations for authors who wish to submit 
their work to Biochemia Medica. It should however 
be made clear that this article by no means pro-
vides a substitute for a comprehensive textbook in 
biostatistics. On contrary, readers are encouraged 
to take this only as a reminder and to consult a 
textbook for a more comprehensive coverage of 
the issues mentioned in this article.
Are key results included in the Abstract?
One of the most important parts of the article is 
the Abstract. Authors quite often forget that Ab-
stract is sometimes the fi rst (and only) part of the 
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article read by the readers. As stated in the Instruc-
tions to authors, Abstract for all original articles 
must be structured into following four headings: 
Introduction, Materials and methods, Results and 
Conclusions. Furthermore, Abstract must be com-
prehensive and provide key results of the study. If 
not done so already in the Materials and methods 
section of the Abstract, authors certainly need to 
make sure that readers are informed about the 
number and size of the studied groups. All esti-
mates need to be presented with the appropriate 
summary measures, confi dence intervals and P 
values (where applicable). For all tested diff erences 
and associations, the level of signifi cance must be 
provided.
applied in the study. From this section, every read-
er should be able to understand which test exactly 
was used for every comparison of the data pre-
sented with the Results section. At the end of the 
Statistical analysis, authors need to state the level 
of signifi cance applied in their study and statistical 
program used.
When writing the section Statistical analysis, au-
thors need to make sure to address all issues listed 
below:
What kind of data did they have (categorical or • 
numerical)?
How did they describe their data?• 
Did they test their distributions for normality? The • 
name of the normality test needs to be stated.
How was statistical test chosen to test the pos-• 
sible diff erences and associations between their 
data?
Which statistical test was used for analyzing their • 
categorical data?
Were the groups large enough to detect the ex-• 
pected eff ect?
What was the level of signifi cance in their anal-• 
ysis?
Which statistical software did they use? The ver-• 
sion of the software and complete information 
on the manufacturer of the statistical software 
must be provided.
Below is the example for poorly written
Results section of the Abstract:
Results: The concentration of New BioMarker™ 
in patients with acute myocardial infarction was 
higher than in healthy controls (P < 0.05). There 
was a signifi cant correlation of New BioMarker™ 
with serum copeptine concentrations.
The following is the example for well written 
Results section of the Abstract:
Results: There were 250 patients with acute my-
ocardial infarction and 232 healthy controls. The 
concentration of New BioMarker™ was higher in 
patients than in healthy controls (7.3 ± 0.6 
mmol/L vs. 5.4 ± 0.5 mmol/L, respectively; P = 
0.002). New BioMarker™ was associated with se-
rum copeptine concentration (r = 0.67, P = 0.026). 
Is Statistical analysis section written well, 
accurate and comprehensive?
Problematic section often neglected by authors is 
Statistical analysis as the subheading within the 
section Materials and methods. Within the sub-
heading Statistical analysis authors need to explain 
which statistical tests were used in their data anal-
ysis and the rationale for using those tests. Care 
must be taken to assure that: a) all tests used are 
listed in the Materials and methods under Statistical 
analysis, as well as b) that all tests listed are indeed 
The following is the example for poorly writ-
ten Statistical analysis subheading of the 
Materials and methods section:
Statistical analysis
Data were presented as mean ± standard devia-
tion. Diff erences were tested by t-test. Pearson 
correlation was used to analyze the association 
between all studied parameters. Data analysis 
was done using MedCalc.
The following is the example for well written 
Statistical analysis subheading of the Materi-
als and methods section:
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Key points to keep in mind when writing 
the Results section
The next section that should be carefully inspect-
ed prior of submitting, to detect for any possible 
fl aws and errors in data analysis and presentation 
is Result section.
When results are reported, authors need to make 
sure that:
Their descriptive analysis is appropriate;• 
They have presented their results with ade-• 
quate precision and accurately;
They have provided the measure of confi dence • 
for all estimates, if necessary and applicable;
They have used correct statistical tests for their • 
analysis;
Their graphs and tables are informative;• 
They have provided P value for all tests done in • 
their work;
They are not making any conclusions on the • 
causal relationship unless their study is an ex-
periment or a clinical trial.
This is, unfortunately, not always the case. Authors 
quite often fail to describe their data with ade-
quate precision and by using the appropriate sum-
mary measures. Quite often, it is not clear from the 
text whether the assumptions for tests were met 
and have appropriate tests been used in the data 
analysis. This part of the manuscript is crucial and 
needs to be written with great attention and care. 
To help our readers to avoid all possible mistakes 
below we summarize some key points they need 
to keep in mind when writing Results section of 
their manuscripts.
Is the descriptive analysis adequate?
When describing numerical data, it is essential that 
proper measures of central tendency and disper-
sion are used. Before presenting the data, normal-
ity of the distributions needs to be tested. Gener-
ally speaking, if the data are normally distributed 
and if sample size is ≥ 30, parametric summary 
measures (mean and standard deviation) may be 
used. However, if sample size is small (N < 30) or if 
data are not normally distributed, authors are ad-
vised to use median and interquartile range (IQR), 
from fi rst (Q1) to third quartile (Q3) or some other 
measures, like range. We wish to point out that 
there is no uniformly accepted opinion about the 
cut-off  number for the sample size, but according 
to Dawson and Trapp, samples under 30 subjects 
per group are considered small and require non-
parametric statistics (5).
Since SEM (standard error of the mean) is not the 
measure of dispersion, its use is not allowed when 
summarizing and describing the data. Using SEM 
instead of standard deviation is one of the ten 
most common mistakes occurring in the manu-
scripts submitted to biomedical journals (6).
More extensive review on the ways of summariz-
ing and interpreting numerical data has recently 
been published in this journal within the section 
Lessons in biostatistics (7) and elsewhere (8).
Are results presented with adequate precision 
and accurately?
The golden rule is to present the data with the pre-
cision which corresponds to the precision of the 
raw data obtained by the measurement. For in-
stance, when reporting the number of cigarettes 
smoked in some studied period, it is completely 
unnecessary and wrong to state that the number 
of cigarettes was: 10.21 ± 3.16. This is wrong be-
cause the reported precision does not correspond 
to the precision of the measurement. The number 
of cigarettes is measured by counting. So, the ob-
Statistical analysis
The Kolmogorov-Smirnov test was used to as-
sess the normality of distribution of investigated 
parameters. All parameters in our study were 
distributed normally. Data were expressed as 
mean ± standard deviation. Diff erences were 
tested by two-tailed t-test. Pearson’s correlation 
was used to analyze the association between all 
studied parameters. The values P < 0.05 were 
considered statistically signifi cant. Statistical 
analysis was done using MedCalc 12.1.4.0 statis-
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served number of cigarettes should be the whole 
number, without any decimals: 10 ± 3.
Example for the fl awed data presentation of the 
observations is provided in the Table 1a.
The problem with data presented in Table 1a is that 
all three parameters were presented with inade-
quate precision which does not correspond to the 
precision of the way those data were measured:
Age is usually expressed with years and only • 
one decimal is allowed, if absolutely necessary. 
Only when children are studied, it makes sense 
to provide age in months and even days. Moreo-
ver, age is usually reported as median and range 
(min-max). So, instead of stating that average 
age was 55.905 ± 2.112 years, it needs to be stat-
ed that the average age was 56 (51-60) years.
The mean and measure of dispersion (standard • 
deviation) for all laboratory parameters needs 
to be presented with as many decimals as the 
results are usually reported on the laboratory 
test report. It is therefore improper to present 
the WBC data with three decimals, since this 
parameter is usually measured and reported 
with only one decimal. So, instead of stating 
that WBC number in group A was 13.177 (6.837-
15.272) x 109/L, authors should report that WBC 
was 13.2 (6.8-15.3) x 109/L.
Finally, due to the small number of subjects in • 
both groups, the ratio of females in both groups 
needs to be provided as the number of the ob-
servations divided with the total number of 
subjects within the group (6/11 and 8/14 in-
stead of 54.5% and 57.1%).
General rules when reporting frequencies are list-
ed below:
Percentages are not recommended if the • 
number of subjects in the group is < 100. In-
stead, ratios should be used (for example, 0.67 
instead of 67%).
Percentages should be presented as whole • 
numbers, without decimals. The exception are 
percentages < 10%, where one decimal place is 
allowed, only if necessary and applicable (for 
example, if percentage is 0.3%).
For small samples (N < 30), the use of percent-• 
ages and ratios is not recommended. When 
their sample size is small, authors are advised to 
present their data with the number of the ob-
servations divided with the total number of 
subjects within the group (for example, 3/11, in-
stead of 27%).
Correct way to present data is provided in Table 1b.
When necessary and applicable, the authors need 




(N = 14) P
Age (years) 55.905 ± 2.112 58.107 ± 4.016 0.687
WBC (x 109/L) 13.177 (6.837-15.272) 6.898 (3.283-11.496) 0.207
Female, N (%) 6 (54.5%) 8 (57.1%) 0.783
WBC - white blood cells
TABLE 1A. The example for erroneously presented results for observations in two groups (groups A and B).




(N = 14) P
Age (years) 56 (51-60) 58 (52-63) 0.687
WBC (x109/L) 13.2 (6.8-15.3) 6.9 (3.3-11.5) 0.207
Female, N/total 6/11 8/14 0.783
WBC - white blood cells
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and P value for all their estimates. This is especially 
important when presenting estimates of diagnos-
tic accuracy, odds ratios, relative risks, regression 
analysis results etc. In the Tables 2a and 2b, we list 
some most common examples for fl awed and cor-
rect presentation of your estimates.
It is noteworthy to mention that AUC is always re-
ported with two decimal places, as well as its up-
per and lower 95% confi dence interval limits.
Were correct statistical tests used for the
analysis?
The choice of statistical test is determined by the 
type of the data and the way they are measured. 
There are several assumptions that need to be 
checked prior to the choice of the test:
Are data normally distributed?• 
Are data numerical or categorical?• 
How many groups do authors have?• 
How big are the studied groups?• 
Are the measurements independent?• 
Depending on the answers to the above listed ques-
tions, researcher makes the choice of the statistical 
test. Common errors are: i) authors did not test for 
those assumptions prior to the applying the statisti-
cal test; or ii) they fail to describe the way the test 
was selected; or iii) reader is not informed at all 
about the test used to analyze data in the study.
If data are not normally distributed and/or if sam-
ple size is small (N < 30), non-parametric tests 
should be used.
Tom Lang has reviewed 20 most common statisti-
cal errors occurring in biomedical research articles 
and has provided statistical reporting guidelines 
to be followed by authors, editors, and reviewers 
who lack some knowledge about the statistical 
analysis (6). Listed below are some of the most 
commonly errors occurring in manuscripts submit-
ted to Biochemia Medica:
Normality is not tested and statistical test is • 
used without the knowledge of the data distri-
bution, or regardless to the sample size.
Group A P
Sensitivity %, (95% Ci) 92 (88-97) 0.021
AUC (95% Ci) 0.78 (0.63-0.89) 0.038
Odds ratio (95% Ci) 2.5 (1.7-12.3) 0.019
AUC - area under the curve
TABLE 2A. Examples for fl awed presentation of results.





AUC - area under the curve
The reason why confi dence intervals are important 
is because they show how precise is the corre-
sponding estimate. If confi dence interval is too 
wide, this means that the precision of the estimate 
is small. Confi dence intervals may be used to as-
sess the diff erence between two estimates. For ex-
ample, if authors wish to compare two areas under 
the curve (AUC) for two parameters, it needs to be 
checked if their confi dence intervals overlap. In 
case those two confi dence intervals overlap, it may 
be concluded that there is no statistically signifi -
cant diff erence in the AUC for those two parame-
ters at the corresponding level of signifi cance rela-
tive to the confi dence interval. More extensive re-
view on the use and interpretation of the confi -
dence intervals has already been published in this 
Journal within the section Lessons in biostatistics (9).
ing 95% confi dence intervals are 0.78 (0.63-0.89) 
and 0.99 (0.80-0.99). The question is: is there a 
statistically signifi cant diff erence in the AUC for 
parameters A and B? Since their 95% confi dence 
intervals overlap (from 0.80 to 0.89) we may con-
clude that there is no statistically signifi cant dif-
ference in those two parameters, for the signifi -
cance level alpha = 0.05.
Example:
Let us say that we wish to compare the AUC for 
parameter A and B. Their AUC and correspond-
Biochemia Medica 2012;22(1):15–23
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Paired statistical test is not used, although de-• 
pendent observations (for example, repeated 
measurements) are tested.
Chi-square test is used even if total number of • 
observations or the number of expected fre-
quencies in the 2x2 table is low.
Pearson’s coeffi  cient of correlation is calculated • 
even if one variable is measured using the ordi-
nal scale or data distribution signifi cantly devi-
ates from normal distribution.
Diff erences between three or more groups are • 
tested with t-test, instead of tests like ANOVA or 
Kruskal-Walis test.
If there are three or more groups, authors should 
use ANOVA or its non-parametric analogue. When 
testing the data with tests for testing diff erences 
between three or more groups (such as ANOVA or 
Kruskal-Walis test), authors need to make sure to 
give P value for ANOVA as well as for post-hoc com-
parisons.
Only if P for ANOVA or Kruskal-Walis test implies 
that the tested diff erence among groups is signifi -
cant, authors may proceed with post hoc test for 
multiple comparisons. Post hoc test is not done if P 
> 0.05, when applying tests for testing diff erences 
between three or more groups.
Furthermore, what also needs to be stated is the 
name of the test used for post-hoc comparisons, 
because diff erent tests have diff erent uses, as well 
as advantages and disadvantages (10).
Authors need to make sure that all tests used in 
their work have met the assumptions for their use 
and this information needs to be provided to the 
readers in the sections Statistical analysis and Re-
sults. More comprehensive review on the choice of 
the right statistical test has been extensively elab-
orated in this Journal within the section Lessons in 
biostatistics (11).
Is P value provided for all tests done in the 
study?
P value needs to be stated as exact number with 
three decimal places (i.e. P = 0.027). The use of ex-
pressions like NS, P > 0.05, P < 0.05 and P = 0.0000 
is strongly discouraged. P should be provided with 
capital letter and should not be italicized. P < 0.001 
is the smallest P value that should be reported. 
There is no point to provide more than 3 decimals 
for P, with the exception of some studies when 
large samples and rare events are studied (12).
Data interpretation
Even if correct statistical test was used to analyze 
the data, mistakes can still occur when authors in-
terpret their results. When interpreting the data 
and results, authors need to make sure to take into 
account the a priori stated level of signifi cance. This 
means that diff erences may be interpreted as sig-
nifi cant, only if P value is below the stated level of 
signifi cance. Expressions like ‘borderline signifi cant’ 
are strongly discouraged and will not be accepted.
Furthermore, statements like this are also discour-
aged:
We have observed the diff erence between our • 
study groups, although not statistically signifi -
cant.
Though not statistically signifi cant, concentra-• 
tion of glucose was higher in females than in 
males.
There was a trend towards higher values of • 
marker X with increasing concentrations of 
marker Y. The observed association was unfor-
tunately not statistically signifi cant.
If statistical signifi cance was not observed, data 
should not be reported and discussed as signifi -
cant. Moreover, no matter how obvious, diff erence 
should not be discussed unless the authors have 
tested for its statistical signifi cance. Unfortunately, 
this often occurs when diff erences between two 
or more measures of diagnostic accuracy (AUC, 
sensitivities and specifi cities), correlation coeffi  -
cients and odds ratios are being discussed.
Correlation analysis
Interpretation of the results of correlation analysis 
is frequently incorrect. When interpreting the re-
sults of the correlation analysis, authors fi rst need 
to explore the level of the signifi cance of the cor-
relation coeffi  cient. Correlation coeffi  cient may be 
interpreted only if signifi cant. If the obtained P val-
ue is > 0.05 (or above the predetermined level of 
signifi cance), correlation coeffi  cient is not signifi -
cant and should not be interpreted.
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When interpreting the value of the correlation co-
effi  cient, authors should follow the generally ac-
cepted classifi cation by Colton (1974) (5). There is 
no correlation between the data if r < 0.25, even if 
P value is very low. The use and interpretation of 
correlation analysis is nicely reviewed by Udovicic 
M et al. in Biochemia Medica (13).
Conclusions on the causal relationship
When there is an association between measured 
parameters, authors often tend to make conclu-
sions on the causal relationship of their observa-
tions. This is strongly discouraged. The existence 
of association does not prove the causal relation-
ship of the data.
For example, the association of higher body 
mass index (BMI) with increased serum C-reac-
tive protein (CRP) levels does not prove that CRP 
induces the increase in BMI, nor that BMI in-
crease induces the increase in CRP. This only 
means that people with higher BMI tend to have 
higher concentrations of CRP. 
Only if the study is an experiment or clinical trial, 
authors are allowed to make conclusions on the 
causality of the data. Since most of the studies 
submitted to our Journal are observational (i.e. re-
searcher only observes the diff erences, associa-
tions in variables of interest, without any interven-
tion of the investigator on the study population), it 
is not acceptable to report any eff ect or induction 
of measured parameters. Furthermore, if the study 
is observational and involves monitoring of some 
parameters over time, it is justifi able to report the 
increase and decrease of monitored parameter. 
Otherwise, expressions like increase and decrease 
are not acceptable and authors are encouraged to 
use expressions like higher and lower, instead.
Listed below are several examples of incorrect 
statements which are strongly discouraged for all 
observational studies (which did not involve moni-
toring of parameters of interest over time). Each in-
correct statement is followed by a suggestion for 
revised, correct expression.
Incorrect: Compared with the control group, 
ox-LDL levels were signifi cantly increased in pa-
tients on hemodialysis (P = 0.001).
Correct: Compared with the control group, ox-
LDL levels were signifi cantly higher in patients 
on hemodialysis (P = 0.001).
Incorrect: We found a signifi cantly decreased 
level of GPx in blood of asthmatic children as 
compared to age and sex matched controls 
(13.61 ± 5.73 vs. 15.22 ± 6.75, respectively; P = 
0.036).
Correct: We found a signifi cantly lower level of 
GPx in blood of asthmatic children as compared 
to age and sex matched controls (13.61 ± 5.73 vs. 
15.22 ± 6.75, respectively; P = 0.036).
Incorrect: We observed that carrying AA geno-
type is signifi cantly increased in healthy controls 
compared to patients (OR 2.5, 95% Ci = 1.7-3.9; P 
= 0.012,).
Correct: We observed that frequency of AA 
genotype is signifi cantly higher in healthy con-
trols compared to patients (OR 2.5, 95% Ci = 1.7-
3.9; P=0.012).
Incorrect: Obstructive sleep apnea induced the 
increase in concentrations of hsCRP compared 
to healthy controls (P = 0.045).
Correct: Concentrations of hsCRP were higher 
in children with obstructive sleep apnea, com-
pared to healthy controls (P=0.045).
Incorrect: Logistic regression identifi ed serum 
copeptin (OR 3.1; 95% Ci = 1.7-12.4; P = 0.043) as 
an independent predictor of 1-month mortality 
of patients suff ering from traumatic brain injury. 
We therefore conclude that copeptin induces 
mortality after traumatic brain injury.
Correct: Logistic regression identifi ed serum 
copeptin (OR 3.1; 95% Ci = 1.7-12.4; P = 0.043) as 
an independent predictor of 1-month mortality 
of patients suff ering from traumatic brain injury. 
We therefore conclude that increased serum 
copeptin concentrations are associated with high-
er risk of mortality after traumatic brain injury.
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Checklist
Herein we provide the short checklist for all future 
authors who wish to submit their articles to Bio-
chemia Medica (Table 3). We strongly encourage 
authors to check the items from the checklist prior 
to submitting their work for potential publication 
in our Journal. The aim of the checklist is to remind 
authors to some most important issues related to 
their data analysis and presentation. More exten-
sive checklist for editing and reviewing statistical 
and epidemiological methodology in biomedical 
research papers, has already been published in this 
Journal with the aim to assist statistical reviewers 
and editors as well as to authors when planning 
their study and preparing their manuscripts (14).
Conclusions
Authors are encouraged to browse through some 
older issues of this Journal for some more compre-
hensive coverage of some specifi c statistical terms 
and related issues. The point of this article was to 
provide a more general and basic guidance and 
alert authors to some important key factors that 
need to be remembered when writing an article. 
We invite all future authors to read this article and 
complete the checklist prior to submitting their 
work to our Journal. This will increase the quality 
of the submitted work and speed up the peer-re-
view and publication process for published articles.
Potential confl ict of interest
None declared.
#                 Question Checkbox
Abstract
1 Did you include the key results in your Abstract? □
Materials and methods / Statistical analysis
2 Did you explain the study design and the number of subjects and groups? □
3 Did you list all tests used in your work? □
4 Are all tests listed in Statistical analysis indeed applied in your work? □
5 Have you used correct statistical tests for your analysis?
6 Did you state the level of signifi cance applied in your study? □
7 Did you provide the information about the statistical program (name, version) 
and information on the manufacturer of the program used in your work.
□
Results
8 Have you presented your results with adequate precision and accurately? □
9 Is your descriptive analysis appropriate? □
10 Have you provided the measure of confi dence for all your estimates, if necessary 
and applicable?
□
11 Have you provided P value for all tests done in your work? □
Discussion
12 You are not making any conclusions on the causal relationship unless your study 
is an experiment/trial.
□
TABLE 3. Checklist for authors who submit their work to Biochemia Medica.
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Praktične preporuke za provođenje statističke analize i prikaz podataka u 
časopisu Biochemia Medica
Sažetak
Ovaj članak donosi praktične preporuke temeljene na našem iskustvu kao recenzenata i urednika Časopisa, te upućuje na neke od najčešćih po-
grešaka u rukopisima zaprimljenim u časopis Biochemia Medica. Jedan od najvažnijih dijelova svakog članka jest Sažetak. Autori često zaborave 
da je Sažetak ponekad prvi (i jedini) dio članka koji će čitatelj pročitati. Stoga on mora biti sadržajan i pružiti ključne rezultate istraživanja. Proble-
matičan dio članka, koji autori također često zapostave, jest odlomak Statistička analiza unutar poglavlja Materijali i metode u kojoj autori trebaju 
navesti statističke testove primijenjene u analizi podataka te objasniti način izbora tih testova. Autori također trebaju voditi brigu da su svi testovi 
navedeni u odlomku Statistička analiza doista i primijenjeni u istraživanju, kao i da su svi korišteni testovi zaista navedeni u odlomku Statistička 
analiza. Kod pisanja poglavlja Rezultati potrebno je obratiti pažnju na nekoliko točaka: jesu li rezultati prikazani odgovarajućom preciznošću i 
točnošću, je li deskriptivna analiza prikladna, je li mjera pouzdanosti izražena za sve rezultate (u slučaju da je ona potrebna i primjenjiva), jesu li u 
analizi primijenjeni ispravni statistički testovi, je li za sve testove prikazana P vrijednost itd. Osobito je važno ne stvarati zaključke o uzročno-po-
sljedičnoj vezi, osim u slučaju ako istraživanje predstavlja eksperiment ili klinički pokus. Vjerujemo da bi primjena predloženog Podsjetnika mogla 
unaprijediti kvalitetu zaprimljenih rukopisa te ubrzati njihovu recenziju i postupak objavljivanja članaka.
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